156 related articles for article (PubMed ID: 15734481)
1. The effects of selective nitric oxide synthase blocker on survival, mesenteric blood flow and multiple organ failure induced by zymosan.
Tanriverdi P; Yuksel BC; Rasa K; Guler G; Iskit AB; Guc MO; Korkmaz A
J Surg Res; 2005 Mar; 124(1):67-73. PubMed ID: 15734481
[TBL] [Abstract][Full Text] [Related]
2. The effects of L-NG-nitroarginine in a zymosan-induced multiple organ dysfunction syndrome model.
Ozel H; Yuksel BC; Berkem H; Avsar FM; Guler G; Iskit AB; Guc MO; Hengirmen S
Eur Surg Res; 2009; 43(2):211-8. PubMed ID: 19556797
[TBL] [Abstract][Full Text] [Related]
3. Effect of tempol, a membrane-permeable radical scavenger, on mesenteric blood flow and organ injury in a murine cecal ligation and puncture model of septic shock.
Yuksel BC; Serdar SE; Tuncel A; Uzum N; Ataoglu O; Atan A; Hengirmen S; Iskit AB; Guc MO
Eur Surg Res; 2009; 43(2):219-27. PubMed ID: 19556798
[TBL] [Abstract][Full Text] [Related]
4. Aminoguanidine attenuates endotoxin-induced mesenteric vascular hyporeactivity.
Kavuklu B; Iskit AB; Guc MO; Ilhan M; Sayek I
Br J Surg; 2000 Apr; 87(4):448-53. PubMed ID: 10759741
[TBL] [Abstract][Full Text] [Related]
5. Chronic type IV phosphodiesterase inhibition protects glomerular filtration rate and renal and mesenteric blood flow in a zymosan-induced model of multiple organ dysfunction syndrome treated with norepinephrine.
Thomas NJ; Carcillo JA; Herzer WA; Mi Z; Jackson EK
J Pharmacol Exp Ther; 2001 Jan; 296(1):168-74. PubMed ID: 11123377
[TBL] [Abstract][Full Text] [Related]
6. Evidence that aminoguanidine inhibits endotoxin-induced bacterial translocation.
Kavuklu B; Agalar C; Guc MO; Sayek I
Br J Surg; 1998 Aug; 85(8):1103-6. PubMed ID: 9718006
[TBL] [Abstract][Full Text] [Related]
7. The role of selective nitric oxide synthase inhibitor on nitric oxide and PGE2 levels in refractory hemorrhagic-shocked rats.
Md S; Moochhala SM; Siew Yang KL; Lu J; Anuar F; Mok P; Ng KC
J Surg Res; 2005 Feb; 123(2):206-14. PubMed ID: 15680380
[TBL] [Abstract][Full Text] [Related]
8. Liver tissue inducible nitric oxide synthase (iNOS) expression and lipid peroxidation in experimental hepatic ischemia reperfusion injury stimulated with lipopolysaccharide: the role of aminoguanidine.
Yaylak F; Canbaz H; Caglikulekci M; Dirlik M; Tamer L; Ogetman Z; Polat Y; Kanik A; Aydin S
J Surg Res; 2008 Aug; 148(2):214-23. PubMed ID: 18222473
[TBL] [Abstract][Full Text] [Related]
9. The tyrosine kinase inhibitor tyrphostin AG 126 reduces the multiple organ failure induced by zymosan in the rat.
Dugo L; Chatterjee PK; Mazzon E; McDonald MC; Paola RD; Fulia F; Caputi AP; Thiemermann C; Cuzzocrea S
Intensive Care Med; 2002 Jun; 28(6):775-88. PubMed ID: 12107686
[TBL] [Abstract][Full Text] [Related]
10. Absence of endogenous interleukin-10 enhanced organ dysfunction and mortality associated to zymosan-induced multiple organ dysfunction syndrome.
Malleo G; Mazzon E; Genovese T; Di Paola R; Caminiti R; Esposito E; Bramanti P; Cuzzocrea S
Cytokine; 2008 Feb; 41(2):136-43. PubMed ID: 18160304
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-10 reduces morbidity and mortality in murine multiple organ dysfunction syndrome (MODS).
Ferrer TJ; Webb JW; Wallace BH; Bridges CD; Palmer HE; Robertson RD; Cone JB
J Surg Res; 1998 Jul; 77(2):157-64. PubMed ID: 9733603
[TBL] [Abstract][Full Text] [Related]
12. Tyrphostin AG-490 inhibited the acute phase of zymosan-induced inflammation.
Dimitrova P; Ivanovska N
Int Immunopharmacol; 2008 Nov; 8(11):1567-77. PubMed ID: 18656556
[TBL] [Abstract][Full Text] [Related]
13. Etanercept reduces acute tissue injury and mortality associated to zymosan-induced multiple organ dysfunction syndrome.
Malleo G; Mazzon E; Genovese T; Di Paola R; Muià C; Caminiti R; Esposito E; Di Bella P; Cuzzocrea S
Shock; 2008 May; 29(5):560-71. PubMed ID: 17724436
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of inducible nitric oxide synthase ameliorates lung injury in rats after gut ischemia-reperfusion.
Uchida K; Mishima S; Ohta S; Yukioka T
J Trauma; 2007 Sep; 63(3):603-7. PubMed ID: 18073607
[TBL] [Abstract][Full Text] [Related]
15. Effects of chronic inhibition of inducible nitric oxide synthase in hyperthyroid rats.
Rodríguez-Gómez I; Wangensteen R; Moreno JM; Chamorro V; Osuna A; Vargas F
Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1252-7. PubMed ID: 15644461
[TBL] [Abstract][Full Text] [Related]
16. [The effect of aminoguanidine, a nitric oxide synthase inhibitor, on bleomycin-induced lung injury in rats].
Hu J; Xu Q; Li B
Zhonghua Jie He He Hu Xi Za Zhi; 1999 Jan; 22(1):51-3. PubMed ID: 11812359
[TBL] [Abstract][Full Text] [Related]
17. The effects of bosentan, aminoguanidine and L-canavanine on mesenteric blood flow, spleen and liver in endotoxaemic mice.
Iskit AB; Sungur A; Gedikoglu G; Guc MO
Eur J Pharmacol; 1999 Aug; 379(1):73-80. PubMed ID: 10499374
[TBL] [Abstract][Full Text] [Related]
18. Organ damage in zymosan-induced multiple organ dysfunction syndrome in mice is not mediated by inducible nitric oxide synthase.
Volman TJ; Goris RJ; van der Jagt M; van de Loo FA; Hendriks T
Crit Care Med; 2002 Jul; 30(7):1553-9. PubMed ID: 12130978
[TBL] [Abstract][Full Text] [Related]
19. alpha2-Adrenoceptor subsensitivity in mesenteric vascular bed of cholestatic rats: the role of nitric oxide and endogenous opioids.
Borhani AA; Houshmand G; Samini M; Namiranian K; Hajrasouliha AR; Tavakoli S; Ebrahimi F; Dehpour AR
Eur J Pharmacol; 2005 May; 514(2-3):183-9. PubMed ID: 15910805
[TBL] [Abstract][Full Text] [Related]
20. Inducible nitric oxide synthase knockout mice exhibit resistance to the multiple organ failure induced by zymosan.
Cuzzocrea S; Mazzon E; Dugo L; Barbera A; Centorrino T; Ciccolo A; Fonti MT; Caputi AP
Shock; 2001 Jul; 16(1):51-8. PubMed ID: 11442316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
